Development of next generation adeno-associated viral vectors capable of selective tropism and efficient gene delivery
- 1 February 2016
- journal article
- Published by Elsevier BV in Biomaterials
- Vol. 80, 134-145
- https://doi.org/10.1016/j.biomaterials.2015.11.066
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Three-Year Follow-up after Unilateral Subretinal Delivery of Adeno-Associated Virus in Patients with Leber Congenital Amaurosis Type 2Ophthalmology, 2013
- Adenovirus-Associated Virus Vector–Mediated Gene Transfer in Hemophilia BNew England Journal of Medicine, 2011
- Enhanced Real-Time Monitoring of Adeno-Associated Virus Trafficking by Virus–Quantum Dot ConjugatesACS Nano, 2011
- Innate Immune Responses to AAV VectorsFrontiers in Microbiology, 2011
- A viral assembly factor promotes AAV2 capsid formation in the nucleolusProceedings of the National Academy of Sciences of the United States of America, 2010
- Reengineering a receptor footprint of adeno-associated virus enables selective and systemic gene transfer to muscleNature Biotechnology, 2010
- A muscle-targeting peptide displayed on AAV2 improves muscle tropism on systemic deliveryGene Therapy, 2009
- Treatment of Leber Congenital Amaurosis Due toRPE65Mutations by Ocular Subretinal Injection of Adeno-Associated Virus Gene Vector: Short-Term Results of a Phase I TrialHuman Gene Therapy, 2008
- Effect of Gene Therapy on Visual Function in Leber's Congenital AmaurosisNew England Journal of Medicine, 2008
- Virus trafficking – learning from single-virus trackingNature Reviews Microbiology, 2007